Assessment of Risk Evaluation and Mitigation Strategies in Oncology: Summary of the Oncology Risk Evaluation and Mitigation Strategies Workshop-Reference-Cited by-同舟云学术

Assessment of Risk Evaluation and Mitigation Strategies in Oncology: Summary of the Oncology Risk Evaluation and Mitigation Strategies Workshop

Published:2013-03 Issue:2 Volume:9 Page:e24-e39
ISSN:1554-7477
Container-title:Journal of Oncology Practice
language:en
Short-container-title:JOP

Author:

Frame James N.¹,Jacobson Joseph O.¹,Vogel Wendy H.¹,Griffith Niesha¹,Wariabharaj Darshan¹,Garg Rekha¹,Zon Robin¹,Stephens Cyntha L.¹,Bialecki Alison M.¹,Bruinooge Suanna S.¹,Allen Steven L.¹

Affiliation:

1. David Lee Cancer Center, Charleston Area Health Center Medical Systems, Charleston, WV; Dana Farber Cancer Institute, Boston, MA; Kingsport Hematology Oncology Associates, Kingsport, TN; The Ohio State University Comprehensive Cancer Center-The Arthur G. James Cancer Hospital, Columbus, OH; Novartis, East Hanover, NJ; Amgen, Thousand Oaks, CA; Michiana Hematology Oncology, South Bend, IN; American Society of Clinical Oncology, Alexandria, VA; and North Shore University Hospital-Long Island Jewish Medical...

Abstract

Increased provider and professional society participation should form the basis of ongoing and future REMS standardization discussions with the FDA to work toward overall improvement of risk communication.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Health Policy,Oncology (nursing),Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JOP.2012.000620

Reference11 articles.

1. NCCN Oncology Risk Evaluation and Mitigation Strategies White Paper: Recommendations for Stakeholders

2. A Baciu, K Stratton, SP Burke : The Future of Drug Safety: Promoting and Protecting the Health of the Public 2007 Washington, DC Institute of Medicine of the National Academies

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Building a Sustainable Comprehensive Multiple Myeloma Program in Western Kenya;JCO Global Oncology;2021-03

2. A qualitative evaluation of patient and healthcare provider knowledge, attitudes, and behavior for safety and use of pexidartinib;Journal of Comparative Effectiveness Research;2021-02

3. Adaptation for Regulatory Application: A Content Analysis of FDA Risk Evaluation and Mitigation Strategies Assessment Plans (2014–2018) Using RE-AIM;Frontiers in Public Health;2020-02-25

4. Evaluating REMS Burden: A Comparative Time Analysis of 3 Channels for REMS Stakeholders to Perform Mandatory REMS Tasks;Therapeutic Innovation & Regulatory Science;2020-01-06

5. Evaluating REMS Burden: A Comparative Time Analysis of 3 Channels for REMS Stakeholders to Perform Mandatory REMS Tasks;Therapeutic Innovation & Regulatory Science;2019-04-04